CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities
Net loss	$ (5,993,000)	$ (8,055,000)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	134,000	86,000
Amortization of debt issuance costs	286,000	145,000
Reduction in accounts payable and accrued liabilities from the expiration of statute of limitations	(216,000)	(228,000)
Change in fair value of derivative liabilities		4,679,000
Warrants issued in lieu of cash paid for services	53,000	108,000
Stock-based compensation	634,000	411,000
Change in assets and liabilities
Accounts receivable	41,000	15,000
Inventory	(275,000)	(226,000)
Other assets	36,000	41,000
Accounts payable	190,000	(212,000)
Deferred revenue	333,000	549,000
Accrued expenses	128,000	41,000
Pension obligation	10,000	41,000
Total adjustments	1,354,000	5,450,000
Net cash used in operating activities	(4,639,000)	(2,605,000)
Cash flows from investing activities
Purchase of property and equipment	(100,000)	(103,000)
Net cash used in investing activities	(100,000)	(103,000)
Cash flows from financing activities
Proceeds from exercised stock options	59,000	8,000
Proceeds from exercised warrants to purchase stock	2,798,000	2,014,000
Dividends paid	(25,000)	(25,000)
Net cash provided by financing activities	2,832,000	1,997,000
Effect of exchange rate changes on cash	32,000	(46,000)
Net decrease in cash and cash equivalents	(1,875,000)	(757,000)
Cash and cash equivalents at beginning of period	2,363,000	4,225,000
Cash and cash equivalents at end of period	488,000	3,468,000
Supplemental disclosure of cash flow information:
Cash paid for interest	2,000
Cash paid for income taxes	1,000	1,000
Summary of non-cash investing and financing activities:
Reclassification of warrants previously classified as derivative liabilities to additional paid-in capital	57,000	6,276,000
Issuance of common stock warrants securing line of credit borrowing facility	127,000	580,000
Issuance of common stock pursuant to cashless warrant exercises	9,000	43,000
Issuance of common stock pursuant to conversion of Related-Party notes payable and accrued  interest	85,000
Issuance of common stock pursuant to achievement of vesting conditions		$ 1,000